Contact this trialFirst, we need to learn more about you.
Proteasome Inhibitor
Bortezomib +2 More for Multiple Myeloma
Recruiting1 awardPhase 2
Birmingham, Alabama
This trial studies how well treatment works in reducing multiple myeloma cells to <1 out of 100k in bone marrow after 6 cycles of treatment & whether more patients can be and stay MRD "negative" with 3 additional cycles.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.